Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

CUSIP: 185063104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
76,991,404
Total 13F shares
7,745,921
Share change
-92,214
Total reported value
$9,061,432
Put/Call ratio
21%
Price per share
$1.17
Number of holders
46
Value change
+$2,013
Number of buys
18
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 185063104?
CUSIP 185063104 identifies CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2023

As of 31 Dec 2023, Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,745,921 shares. The largest 10 holders included VANGUARD GROUP INC, Carmignac Gestion, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO. LLC., JOHNSON & JOHNSON, and MORGAN STANLEY. This page lists 46 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.